Loading clinical trials...
Loading clinical trials...
Prospective Evaluation of Xerava™ (Eravacycline) Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
Conditions
Interventions
Eravacycline
Locations
1
United States
Aaron Cumpston
Morgantown, West Virginia, United States
Start Date
February 19, 2024
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2028
Last Updated
April 16, 2026
NCT06056297
NCT07300735
NCT04841447
NCT06999954
NCT06788691
NCT05626530
Lead Sponsor
West Virginia University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions